Case Western Reserve researchers use AI with routine CT scans to predict how well lung cancer patients will respond to expensive treatment based off changes in texture patterns inside and outside the tumor.
Scientists from the Case Western Reserve University digital imaging lab, already pioneering the use of Artificial Intelligence (AI) to predict whether chemotherapy will be successful, can now determine which lung-cancer patients will benefit from expensive immunotherapy.
And, once again, they’re doing it by teaching a computer to find previously unseen changes in patterns in CT scans taken when the lung cancer is first diagnosed compared to scans taken after the first 2-3 cycles of immunotherapy treatment. And, as with previous work, those changes have been discovered both inside—and outside—the tumor, a signature of the lab’s recent research.
“This is no flash in the pan—this research really seems to be reflecting something about the very biology of the disease, about which is the more aggressive phenotype, and that’s information oncologists do not currently have,” said Anant Madabhushi, whose Center for Computational Imaging and Personalized Diagnostics (CCIPD) has become a global leader in the detection, diagnosis and characterization of various cancers and other diseases by meshing medical imaging, machine learning and AI.
Currently, only about 20% of all cancer patients will actually benefit from immunotherapy, a treatment that differs from chemotherapy in that it uses drugs to help your immune system fight cancer, while chemotherapy uses drugs to directly kill cancer cells, according to the National Cancer Institute.
Madabhushi said the recent work by his lab would help oncologists know which patients would actually benefit from the therapy, and who would not.
“Even though immunotherapy has changed the entire ecosystem of cancer, it also remains extremely expensive—about $200,000 per patient, per year,” Madabhushi said. “That’s part of the financial toxicity that comes along with cancer and results in about 42% of all new diagnosed cancer patients losing their life savings within a year of diagnosis.”
Having a tool based on the research being done now by his lab would go a long way toward “doing a better job of matching up which patients will respond to immunotherapy instead of throwing $800,000 down the drain,” he added, referencing the four patients out of five who will not benefit, multiplied by annual estimated cost.
New research published
The new research, led by co-authors Mohammadhadi Khorrami and Prateek Prasanna, along with Madabhushi and 10 other collaborators from six different institutions (see list, below) was published this month in the journal Cancer Immunology Research.
Khorrami, a graduate student working at the CCIPD, said one of the more significant advances in the research was the ability of the computer program to note the changes in texture, volume and shape of a given lesion, not just its size.
“This is important because when a doctor decides based on CT images alone whether a patient has responded to therapy, it is often based on the size of the lesion,” Khorrami said. “We have found that textural change is a better predictor of whether the therapy is working.
“Sometimes, for example, the nodule may appear larger after therapy because of another reason, say a broken vessel inside the tumor—but the therapy is actually working. Now, we have a way of knowing that.”
Prasanna, a postdoctoral research associate in Madabhushi’s lab, said the study also showed that the results were consistent across scans of patients treated at two different sites and with three different types of immunotherapy agents.
“This is a demonstration of the fundamental value of the program, that our machine-learning model could predict response in patients treated with different immune checkpoint inhibitors,” he said. “We are dealing with a fundamental biological principal.”
Prasanna said the initial study used CT scans from 50 patients to train the computer and create a mathematical algorithm to identify the changes in the lesion. He said the next step will be to test the program on cases obtained from other sites and across different immunotherapy agents. This research recently won an ASCO 2019 Conquer Cancer Foundation Merit Award.
Additionally, Madabhushi said, researchers were able show that the patterns on the CT scans which were most associated with a positive response to treatment and with overall patient survival were also later found to be closely associated with the arrangement of immune cells on the original diagnostic biopsies of those patients.
This suggests that those CT scans actually appear to capturing the immune response elicited by the tumors against the invasion of the cancer—and that the ones with the strongest immune response were showing the most significant textural change and most importantly, would best respond to the immunotherapy, he said.
Madabhushi established the CCIPD at Case Western Reserve in 2012. The lab now includes nearly 60 researchers.
Some of the lab’s most recent work, in collaboration with New York University and Yale University, has used AI to predict which lung cancer patients would benefit from adjuvant chemotherapy based on tissue-slide images. That advancement was named by Prevention Magazine as one of the top 10 medical breakthroughs of 2018.
The Latest Google Headlines on:
The Latest Bing News on:
- Immunotherapy is Targeted to Alterations in Tumor Suppressor Geneon March 2, 2021 at 1:45 am
Researchers have developed a novel targeted immunotherapy approach that employs new antibodies against genetically altered proteins to target cancers.
- Future of immunotherapy could be 'off-the-shelf' treatmentson March 2, 2021 at 12:40 am
In a new commentary for the journal Science, an associate vice president for research at The University of Texas at Arlington argues that emerging protein-based immunotherapies could lead to highly ...
- Researchers develop mutant gene-targeted immunotherapy approach to fight cancerson March 1, 2021 at 3:30 pm
A novel targeted immunotherapy approach developed by researchers at the Ludwig Center, the Lustgarten Laboratory, and Bloomberg~Kimmel Institute for Cancer Immunotherapy at the Johns Hopkins Kimmel ...
- Mutant gene-targeted immunotherapy approach developedon March 1, 2021 at 9:35 am
A novel targeted immunotherapy approach developed by researchers at the Ludwig Center, the Lustgarten Laboratory, and Bloomberg-Kimmel Institute for Cancer Immunotherapy at the Johns Hopkins Kimmel ...
- New immunotherapy drugs target two evasive cancer-driving proteinson March 1, 2021 at 8:32 am
The new drugs can lock onto a few snippets of p53 or RAS jutting out from a tumor cell’s surface—and then trigger immune cells to attack them. “The therapies have the potential to work when there’s a ...
- CytoImmune Therapeutics Establishes Operations in Puerto Rico to Develop Novel Cancer Immunotherapy Productson March 1, 2021 at 8:00 am
Invest Puerto Rico (InvestPR), the Island's economic development organization, and the Puerto Rico Department of Economic Development and Commerce (DDEC), today announces that CytoImmune Therapeutics ...
- Immunomodulating nano-adaptors potentiate antibody-based cancer immunotherapyon March 1, 2021 at 4:50 am
Modulating effector immune cells via monoclonal antibodies (mAbs) and facilitating the co-engagement of T cells and tumor cells via chimeric antigen receptor- T cells or bispecific T cell-engaging ...
- ACGT awards $500,000 to advance immunotherapy approach for treating solid tumorson February 28, 2021 at 11:36 pm
A scientific team led by Brian Brown, PhD, Professor of Genetics and Genomic Sciences and Associate Director of the Precision Immunology Institute at the Icahn School of Medicine at Mount Sinai (New ...
- Immunotherapy Drugs Market Share, Demand, Industry Analysis, Growth, Applications, Types and Forecasts Report 2027on February 26, 2021 at 8:14 pm
The global immunotherapy drugs market is projected to be reach USD 365.57 Billion by 2027, according to a current analysis by Emergen Research. The global market for immunotherapy drugs is anticipated ...
- Cancer immunotherapy market is expected to grow CAGR of around 10.6% during the forecast period 2019 to 2026on February 24, 2021 at 3:55 am
The global cancer immunotherapy market is expected to grow at a noteworthy CAGR of around 10.6% during the forecast period 2019 to 2026 The Cancer Immunotherapy Market size is poised to hit around US$ ...
The Latest Google Headlines on:
Artificial intelligence diagnostics
The Latest Bing News on:
Artificial intelligence diagnostics
- More Indian Healthcare Firms to Harness the Power of Artificial Intelligenceon March 2, 2021 at 12:24 am
Recent reports observe that India’s many healthcare firms are now looking at harnessing the power of Artificial Intelligence.
- Nigeria, COVID-19 and Artificial Intelligenceon February 28, 2021 at 4:00 pm
Artificial Intelligence (AI) is the use of digital intelligent networks to perform tasks which require human intelligence. It is the use of data networks, systems and machine learning to perform ...
- Using artificial intelligence to hunt for breast canceron February 27, 2021 at 6:12 am
This makes it easier for breast cancer cells to detach themselves from the tissue - a crucial step in the spreading (metastasis) of tumours. In the E-Morph test, a test substance is given to cultured ...
- Artificial Intelligence (AI) in Breast Cancer Screeningon February 26, 2021 at 9:36 am
Google health division explores whether Artificial Intelligence (AI) models can help reduce the time to breast cancer diagnosis.
- Artificial Intelligence: Leveling The Business Playing Fieldon February 25, 2021 at 5:20 am
Covid-19 has catalyzed the accelerated adoption of AI-based business analytics, workflow and process automation.
- Artificial Intelligence Market Size, Share, Sales Volume and Revenue Growth Analysis Research Report 2026on February 24, 2021 at 9:16 pm
The artificial intelligence market in North America is set for rapid growth. The growth witnessed in this region ...
- How Can Artificial Intelligence Help Medicine?on February 24, 2021 at 9:10 am
Thanks to the technology that we have at our hands these days, our everyday lives are much easier. We are able to complete multiple tasks without even leaving the comfort of our homes, stay updated on ...
- PavMed to spin off subsidiary Lucid Diagnosticson February 23, 2021 at 4:51 am
Pavmed (NSDQ:PAVM) announced today that its majority-owned subsidiary Lucid Diagnostics will spin off into a separate public company.
- Applications of Artificial Intelligence in COVID-19 ICU and ER situationson February 22, 2021 at 5:32 pm
The overwhelming increase in critically ill COVID-19 patients, who urgently require intensive care units (ICU) and emergency departments (ED), has challenged healthcare systems worldwide.
- Take A Look At How Artificial Intelligence Can Improve Your Pet’s Healthon February 22, 2021 at 3:13 pm
Could artificial intelligence give us better insight into our pet's health? How can a data-driven approach help animals live healther, happier lives?